Bifidobacterium bifidum G9-1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open-Label, Randomized Controlled Trial (Binary STAR Study).

Diabetes Obes Metab · 2026 · PMC13243959 · PMID 42017290

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

an increasing trendp = 0.05actually significant

Compared to controls, the BBG9‐1 group showed an increasing trend in the phylum Bacteroidota (mean change: +7.90% vs. +0.88%; p = 0.05).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.